CNPAX
Price
$72.99
Change
-$0.98 (-1.32%)
Updated
Jul 13 closing price
Net Assets
170.23B
SGAAX
Price
$19.52
Change
-$0.02 (-0.10%)
Updated
Jul 13 closing price
Net Assets
148.77M
Interact to see
Advertisement

CNPAX vs SGAAX

CNPAX vs SGAAX Comparison Chart in %
View a ticker or compare two or three
VS
CNPAX vs. SGAAX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNPAX is a Hold and SGAAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CNPAX has more cash in the bank: 170B vs. SGAAX (149M). CNPAX pays higher dividends than SGAAX: CNPAX (0.95) vs SGAAX (0.00). CNPAX was incepted earlier than SGAAX: CNPAX (24 years) vs SGAAX (13 years). SGAAX (1.36) is less costly to investors than CNPAX (0.74). SGAAX is a more actively managed with annual turnover of: 37.00 vs. CNPAX (23.00). SGAAX initial investment is less costly to investors than CNPAX (4%) vs CNPAX (4%). CNPAX has a lower initial minimum investment than SGAAX: CNPAX (250) vs SGAAX (2500). CNPAX annual gain was more profitable for investors over the last year : 7.37 vs. SGAAX (-17.83). CNPAX return over 5 years is better than : 13.82 vs. SGAAX (-37.57).
CNPAXSGAAXCNPAX / SGAAX
Total Expense Ratio0.741.2559%
Annual Report Gross Expense Ratio0.741.3654%
Fund Existence24 years13 years-
Gain YTD5.325-4.729-113%
Front Load4%6%64%
Min. Initial Investment250250010%
Min. Initial Investment IRAN/AN/A-
Net Assets170B149M114,094%
Annual Yield % from dividends0.950.00-
Returns for 1 year7.37-17.83-41%
Returns for 3 years34.17-20.37-168%
Returns for 5 years13.82-37.57-37%
Returns for 10 years115.9125.91447%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FBDIX200.49N/A
N/A
Franklin Biotechnology Discovery A
VGHCX206.44N/A
N/A
Vanguard Health Care Inv
SCETX9.22N/A
N/A
Virtus Ceredex Small-Cap Value Eq I
SEFCX14.37N/A
N/A
SEI International Equity Y (SIT)
VREMX7.87N/A
N/A
Virtus SGA Emerging Markets Equity R6